Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis

NCT00906399 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1516

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Multiple Sclerosis

Interventions

DRUG: BIIB017 (peginterferon beta-1a)
DRUG: Placebo

Sponsor

Biogen